AAAAAA

   
Results: 1-7 |
Results: 7
Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir)
Authors: Sham, HL Betebenner, DA Herrin, T Kumar, G Saldivar, A Vasavanonda, S Molla, A Kempf, DJ Plattner, JJ Norbeck, DW
Citation: Hl. Sham et al., Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir), BIOORG MED, 11(11), 2001, pp. 1351-1353
Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients
Authors: Kempf, DJ Isaacson, JD King, MS Brun, SC Xu, Y Real, K Bernstein, BM Japour, AJ Sun, E Rode, RA
Citation: Dj. Kempf et al., Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients, J VIROLOGY, 75(16), 2001, pp. 7462-7469
Protease inhibitors as anti-human immunodeficiency virus agents
Authors: Kempf, DJ Molla, A Hsu, A
Citation: Dj. Kempf et al., Protease inhibitors as anti-human immunodeficiency virus agents, ANTIRETROVIRAL THERAPY, 2001, pp. 147-174
Ritonavir and saquinavir combination therapy for the treatment of HIV infection
Authors: Cameron, DW Japour, AJ Xu, Y Hsu, A Mellors, J Farthing, C Cohen, C Poretz, D Markowitz, M Follansbee, S Angel, JB McMahon, D Ho, D Devanarayan, V Rode, R Salgo, MP Kempf, DJ Granneman, R Leonard, JM Sun, E
Citation: Dw. Cameron et al., Ritonavir and saquinavir combination therapy for the treatment of HIV infection, AIDS, 13(2), 1999, pp. 213-224
In vitro metabolism of the HIV-1 protease inhibitor ABT-378: Species comparison and metabolite identification
Authors: Kumar, GN Jayanti, V Lee, RD Whittern, DN Uchic, J Thomas, S Johnson, P Grabowski, B Sham, H Betebenner, D Kempf, DJ Denissen, JF
Citation: Gn. Kumar et al., In vitro metabolism of the HIV-1 protease inhibitor ABT-378: Species comparison and metabolite identification, DRUG META D, 27(1), 1999, pp. 86-91
Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P-3 ligands
Authors: Chen, XQ Kempf, DJ Sham, HL Green, BE Molla, A Korneyeva, M Vasavanonda, S Wideburg, NE Saldivar, A Marsh, KC McDonald, E Norbeck, DW
Citation: Xq. Chen et al., Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P-3 ligands, BIOORG MED, 8(24), 1998, pp. 3531-3536
ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease
Authors: Sham, HL Kempf, DJ Molla, A Marsh, KC Kumar, GN Chen, CM Kati, W Stewart, K Lal, R Hsu, A Betebenner, D Korneyeva, M Vasavanonda, S McDonald, E Saldivar, A Wideburg, N Chen, XQ Niu, P Park, C Jayanti, V Grabowski, B Granneman, GR Sun, E Japour, AJ Leonard, JM Plattner, JJ Norbeck, DW
Citation: Hl. Sham et al., ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease, ANTIM AG CH, 42(12), 1998, pp. 3218-3224
Risultati: 1-7 |